The rapid evolution of generative and agentic AI is reshaping how professionals work across industries, particularly in domain-specific markets where deep expertise and proprietary data may create ...

Peter joined Summit Partners in 1994 and focuses primarily on the technology sector. He has invested in more than 30 companies including 18 currently or formerly publicly-traded companies. Peter has ...

Summit is powered by a dedicated team with deep domain expertise in target sectors. Our team includes experienced investors, seasoned executives and knowledgeable operators.

Partnering with organizations across the healthcare ecosystem that are working to make a positive impact on quality, access and efficiency.

Paul first joined Summit Partners as an Associate in 2011. Today, he is a Partner on the Growth Products & Services team. His current board and investment experience includes 48forty Solutions, a.k.a.

"Summit Partners brought invaluable experience in financial services and technology investments, and was uniquely positioned to help drive the rapid expansion of our business." Founded in 2004 and ...

Marty is a Senior Advisor at Summit Partners. He joined the firm in 1985, and he has led investments in and served as a board director of more than 35 companies, including eight public companies. Over ...

Scott joined Summit Partners in 2009 and focuses primarily on the technology sector. His investment and board experience includes Calypso Technology (acquired by Thoma Bravo), HelpSystems (acquired by ...

Chris joined Summit Partners in 2001 and co-leads the Growth Products & Services team. He has served as a board director for many companies and is currently a director of a.k.a. Brands (NYSE: AKA), ...

As an Advisory Partner, Bob works closely with Summit’s investment teams, particularly in the Growth Products & Services and Technology areas, to identify new investment opportunities and collaborate ...

Thomas joined Summit Partners in 2013, and focuses primarily on the healthcare & life sciences sector in Europe. His board and investment experience includes Advance Medical (acquired by Teladoc), ...

RIS Rx is a healthcare technology company delivering real-timegross-to-net (GTN) revenue protection for some of the world's leading pharmaceutical manufacturers. Through proprietary software, ...